ARTICLE

FindCenter AddIcon

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

By Andrew R. Gallimore and Rick J. Strassman — 2016

Using pharmacokinetic modeling and DMT blood sampling data, we demonstrate that the unique pharmacological characteristics of DMT, which also include a rapid onset and lack of acute tolerance to its subjective effects, make it amenable to administration by target-controlled intravenous infusion.

Read on www.frontiersin.org

FindCenter Post-Image

Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems

In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...

Article
Neuroscience News
2022
FindCenter AddIcon
FindCenter Post-Image

A DMT Trip 'Feels Like Dying' - and Scientists Now Agree

A new scientific study suggests strong similarities between near death experiences and the psychedelic drug.

Article
Ben Bryant
2018
FindCenter AddIcon
FindCenter Post-Image

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

Article
Michael Pollan
2015
FindCenter AddIcon
FindCenter Post-Image

My Adventures with the Trip Doctors

My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.

Article
Michael Pollan
2018
FindCenter AddIcon

EXPLORE TOPIC

DMT